Skip to main content

Selank vs Cerebrolysin

Both Selank and Cerebrolysin are used for cognitive. Here's how their evidence, dosing, and regulatory status actually compare.

Selank

Evidence B

Selank (TP-7)

A synthetic analog of tuftsin with anxiolytic and nootropic properties. Modulates GABA and serotonin systems to reduce anxiety without sedation.

View full Selank profile →

Cerebrolysin

Evidence B

Cerebrolysin (porcine brain peptide complex)

A standardized mixture of low-molecular-weight peptides from porcine brain. Decades of stroke, dementia, and TBI trial data — modest but consistent cognitive recovery effects.

View full Cerebrolysin profile →

Side-by-Side

AttributeSelankCerebrolysin
Evidence GradeBB
FDA StatusNot FDA-approved in US — approved in Russia as anxiolyticNot FDA-approved in US — approved in 50+ countries for stroke, traumatic brain injury, and dementia
Typical Dose200–400 mcg intranasal, eveningTrial range: 5–30 mL daily (intravenous infusion)
Clinics Indexed7241
Categoriescognitive, anxietycognitive, neuroprotection

Key reported benefits — Selank

  • Anxiety reduction
  • Stress resilience
  • Cognitive clarity
  • Immune modulation

Key reported benefits — Cerebrolysin

  • Stroke recovery support
  • TBI rehabilitation
  • Cognitive function in dementia

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons